ArticlePharmacology2013

The effect of SV 293, a D2 dopamine receptor-selective antagonist, on D2 receptor-mediated GIRK channel activation and adenylyl cyclase inhibition.

Renqi Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.